Elicio Therapeutics Inc is a clinical-stage biotechnology company developing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic, colorectal, and lung cancers. The company focuses on off-the-shelf therapies using its proprietary Amphiphile (AMP) technology to stimulate T cell responses.
Description via Wikipedia
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.